Allergan successfully completes Kythera acquisition
KYBELLA® first FDA-approved non-surgical injection for submental fullness bolsters Allergan’s world-class facial aesthetics portfolio
Read MorePRIME Journal is part of the Informa Markets Division of Informa PLC
PRIME Journal is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
